APA

Weir M. R., Haskell L., Berger J. S., Ashton V., Laliberté F., Crivera C., Brown K., Lefebvre P. & Schein J. (20180820). Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal function. : Clinical nephrology.

Chicago

Weir Matthew R, Haskell Lloyd, Berger Jeffrey S, Ashton Veronica, Laliberté François, Crivera Concetta, Brown Kip, Lefebvre Patrick and Schein Jeffrey. 20180820. Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal function. : Clinical nephrology.

Harvard

Weir M. R., Haskell L., Berger J. S., Ashton V., Laliberté F., Crivera C., Brown K., Lefebvre P. and Schein J. (20180820). Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal function. : Clinical nephrology.

MLA

Weir Matthew R, Haskell Lloyd, Berger Jeffrey S, Ashton Veronica, Laliberté François, Crivera Concetta, Brown Kip, Lefebvre Patrick and Schein Jeffrey. Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal function. : Clinical nephrology. 20180820.